[
  {
    "ts": "2026-01-02T11:00:00+00:00",
    "headline": "Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 7:30 am Pacific Time.",
    "url": "https://finance.yahoo.com/news/haemonetics-present-44th-annual-j-110000098.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "48a1c487-fa0f-37c2-bb9d-eb7e88497fa2",
      "content": {
        "id": "48a1c487-fa0f-37c2-bb9d-eb7e88497fa2",
        "contentType": "STORY",
        "title": "Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 7:30 am Pacific Time.",
        "pubDate": "2026-01-02T11:00:00Z",
        "displayTime": "2026-01-02T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/512e211fe9b209e3384f3b709e0c679c",
          "originalWidth": 400,
          "originalHeight": 93,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HSX2Y0Dk4KJJnHMuQxkCJw--~B/aD05Mzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/512e211fe9b209e3384f3b709e0c679c.cf.webp",
              "width": 400,
              "height": 93,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I9o0xCFWyplHBs3UOPNJAw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/512e211fe9b209e3384f3b709e0c679c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/haemonetics-present-44th-annual-j-110000098.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/haemonetics-present-44th-annual-j-110000098.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HAE"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T12:00:00+00:00",
    "headline": "Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the J.P. Morgan 2026 Healthcare Conference in San Francisco, on Monday, January 12, 2026, at 3:00 p.m. PT / 6:00 p.m. ET.",
    "url": "https://finance.yahoo.com/news/insmed-present-44th-annual-j-120000623.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "3f937691-e0a2-392c-928c-42869d9e6cba",
      "content": {
        "id": "3f937691-e0a2-392c-928c-42869d9e6cba",
        "contentType": "STORY",
        "title": "Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference",
        "description": "",
        "summary": "Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the J.P. Morgan 2026 Healthcare Conference in San Francisco, on Monday, January 12, 2026, at 3:00 p.m. PT / 6:00 p.m. ET.",
        "pubDate": "2026-01-02T12:00:00Z",
        "displayTime": "2026-01-02T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/af9dece69798605e068fb46028512647",
          "originalWidth": 400,
          "originalHeight": 186,
          "caption": "Insmed-Logo-Purple (PRNewsfoto/Insmed Incorporated)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kvP0fWnQAqRVnsbwTDuWSA--~B/aD0xODY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/af9dece69798605e068fb46028512647.cf.webp",
              "width": 400,
              "height": 186,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_5Pzk70xKAOz18v4cwe7sw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/af9dece69798605e068fb46028512647.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/insmed-present-44th-annual-j-120000623.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/insmed-present-44th-annual-j-120000623.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INSM"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T11:59:00+00:00",
    "headline": "Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference",
    "summary": "PRINCETON, N.J., January 02, 2026--Bristol Myers Squibb to Present at J.P. Morgan's 44th Annual Healthcare Conference",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-present-j-115900859.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "66988d36-b9bc-30e5-b61d-346cbad00eb9",
      "content": {
        "id": "66988d36-b9bc-30e5-b61d-346cbad00eb9",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference",
        "description": "",
        "summary": "PRINCETON, N.J., January 02, 2026--Bristol Myers Squibb to Present at J.P. Morgan's 44th Annual Healthcare Conference",
        "pubDate": "2026-01-02T11:59:00Z",
        "displayTime": "2026-01-02T11:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/38f272e4ec232bf2169bca2d0e8bf2dc",
          "originalWidth": 1497,
          "originalHeight": 206,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PSzgQRatSjYytrS9PEKnog--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/38f272e4ec232bf2169bca2d0e8bf2dc.cf.webp",
              "width": 1497,
              "height": 206,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oOvXraeNaQC5aBPujuC0Gw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/38f272e4ec232bf2169bca2d0e8bf2dc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-present-j-115900859.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-present-j-115900859.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T13:00:00+00:00",
    "headline": "Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results",
    "summary": "Boston Scientific Corporation (NYSE: BSX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, in San Francisco. Mike Mahoney, chairman and chief executive officer, Jon Monson, executive vice president and chief financial officer, and Ken Stein, M.D., senior vice president and global chief medical officer, will participate in a 40-minute question-and-answer session with the host analyst. The session will begin at approximately 9:00 a.m. PT / 12:00",
    "url": "https://finance.yahoo.com/news/boston-scientific-announces-participation-j-130000046.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "f54d7c7a-9821-3edf-973a-f92c95c4e721",
      "content": {
        "id": "f54d7c7a-9821-3edf-973a-f92c95c4e721",
        "contentType": "STORY",
        "title": "Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results",
        "description": "",
        "summary": "Boston Scientific Corporation (NYSE: BSX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, in San Francisco. Mike Mahoney, chairman and chief executive officer, Jon Monson, executive vice president and chief financial officer, and Ken Stein, M.D., senior vice president and global chief medical officer, will participate in a 40-minute question-and-answer session with the host analyst. The session will begin at approximately 9:00 a.m. PT / 12:00",
        "pubDate": "2026-01-02T13:00:00Z",
        "displayTime": "2026-01-02T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888",
          "originalWidth": 400,
          "originalHeight": 209,
          "caption": "Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bqyalFkM.p2vF1LWkaMoDA--~B/aD0yMDk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888.cf.webp",
              "width": 400,
              "height": 209,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Oi.RxhAOmrA0KHLwcormRA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-announces-participation-j-130000046.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-announces-participation-j-130000046.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T14:10:23+00:00",
    "headline": "JPMorgan Boosts Rating on Recursion Pharmaceuticals (RXRX) Amid AI-Driven Drug Pipeline",
    "summary": "Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from a Neutral to an Overweight rating, boosting the price target to $11 from $10. The change follows the solid results of Recursion’s MEK 1/2 inhibitor, REC-4881, which showed potent effectiveness […]",
    "url": "https://finance.yahoo.com/news/jpmorgan-boosts-rating-recursion-pharmaceuticals-141023713.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a05fe9d7-6e40-3e48-98c0-80656efdc25d",
      "content": {
        "id": "a05fe9d7-6e40-3e48-98c0-80656efdc25d",
        "contentType": "STORY",
        "title": "JPMorgan Boosts Rating on Recursion Pharmaceuticals (RXRX) Amid AI-Driven Drug Pipeline",
        "description": "",
        "summary": "Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from a Neutral to an Overweight rating, boosting the price target to $11 from $10. The change follows the solid results of Recursion’s MEK 1/2 inhibitor, REC-4881, which showed potent effectiveness […]",
        "pubDate": "2026-01-02T14:10:23Z",
        "displayTime": "2026-01-02T14:10:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/e064e59836b880f2abe5ba1c0fce3a66",
          "originalWidth": 1920,
          "originalHeight": 1282,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IdJAH7xlT5z0Usubd4WzNQ--~B/aD0xMjgyO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/e064e59836b880f2abe5ba1c0fce3a66.cf.webp",
              "width": 1920,
              "height": 1282,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NdySNIhfoJQSPxvzs_Yikg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e064e59836b880f2abe5ba1c0fce3a66.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-boosts-rating-recursion-pharmaceuticals-141023713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-boosts-rating-recursion-pharmaceuticals-141023713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RXRX"
            },
            {
              "symbol": "JPM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T13:34:38+00:00",
    "headline": "Equities to Get Boost From Robust Earnings in 2026 But Near-Term Fed Path Uncertain, Analysts Say",
    "summary": "US equity markets are poised to get a boost from strong corporate earnings this year as spending con",
    "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "11fc1eab-d54d-3a9d-a538-886fa12cf048",
      "content": {
        "id": "11fc1eab-d54d-3a9d-a538-886fa12cf048",
        "contentType": "STORY",
        "title": "Equities to Get Boost From Robust Earnings in 2026 But Near-Term Fed Path Uncertain, Analysts Say",
        "description": "",
        "summary": "US equity markets are poised to get a boost from strong corporate earnings this year as spending con",
        "pubDate": "2026-01-02T13:34:38Z",
        "displayTime": "2026-01-02T13:34:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "wallstreetsign.jpg - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lI5cIjBjU5eubUz1M.E4aA--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pEfwAFBugUgkoc.pTwU_Jw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]